ArticleBlood2016

Phase 1 studies of central memory-derived CD19 CAR T-cell therapy following autologous HSCT in patients with B-cell NHL.

Xiuli Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.